Kennedy Investment Group Abbott Laboratories Transaction History
Kennedy Investment Group
- $215 Billion
- Q1 2025
A detailed history of Kennedy Investment Group transactions in Abbott Laboratories stock. As of the latest transaction made, Kennedy Investment Group holds 1,700 shares of ABT stock, worth $219,045. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,700Holding current value
$219,045% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,440Shares Held
1.34BCall Options Held
10.5MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$21.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$9.94 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.76 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$6.97 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $226B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...